Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025
Laser and energy-based devices for treating rosacea - a systematic review and network meta-analysis.
СтатьяNetwork Meta-AnalysisСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nguyen Lynhda, Sorbe Christina, Seeber Nikolaus, Schneider Stefan W, Herberger Katharina
Аннотация
BACKGROUND AND OBJECTIVES: Rosacea is a chronic inflammatory condition affecting the central face. While laser and energy-based devices (EBDs) are commonly used for managing vascular symptoms, comprehensive comparisons between systems are limited. This study aims to evaluate and compare the efficacy and safety of lasers and EBDs for rosacea through a systematic review and network meta-analysis (NMA).
METHODS: Randomized controlled trials (RCTs) were identified from MEDLINE, CENTRAL, and Web of Science, with additional searches for ongoing trials. Primary outcomes included patient satisfaction, improvements in erythema and telangiectasia, and long-term adverse events (AEs). Risk of bias (RoB) and publication bias were also assessed.
RESULTS: 25 RCTs were included for qualitative analysis, and subsets contributed to the NMAs. Most studies exhibited unclear or high risk of bias, with a slight publication bias observed. Radiofrequency microneedling was more effective than pulsed dye laser (PDL) in terms of patient satisfaction (MD -1.32; 95 % CI -1.89 to -0.76) and erythema (MD -1.44; 95 % CI -1.96 to -0.91). The combination of oxymetazoline and PDL appeared superior for telangiectasia (MD -0.58; 95 % CI -1.03 to -0.14). AEs and discontinuation rates were comparable across treatments.
METHODS: Randomized controlled trials (RCTs) were identified from MEDLINE, CENTRAL, and Web of Science, with additional searches for ongoing trials. Primary outcomes included patient satisfaction, improvements in erythema and telangiectasia, and long-term adverse events (AEs). Risk of bias (RoB) and publication bias were also assessed.
RESULTS: 25 RCTs were included for qualitative analysis, and subsets contributed to the NMAs. Most studies exhibited unclear or high risk of bias, with a slight publication bias observed. Radiofrequency microneedling was more effective than pulsed dye laser (PDL) in terms of patient satisfaction (MD -1.32; 95 % CI -1.89 to -0.76) and erythema (MD -1.44; 95 % CI -1.96 to -0.91). The combination of oxymetazoline and PDL appeared superior for telangiectasia (MD -0.58; 95 % CI -1.03 to -0.14). AEs and discontinuation rates were comparable across treatments.